Homart Group showcased five brands at the Australian Pharmacy Professional Conference & Trade Exhibition (APP) 2026, recently held on the Gold Coast, Queensland, strengthening its presence in the professional pharmacy channel. Participating through Homart Wellness, the Group presented SpringLeaf, Petmima, Thompson’s, Thursday Plantation and GrandPawPaw to pharmacists, pharmacy owners and industry professionals from across Australia.

During the exhibition, the Homart team engaged directly with pharmacists and pharmacy operators, introducing product features, compliance standards and potential partnership opportunities. The booth attracted strong interest from industry visitors and provided an opportunity for in-depth discussions around product applications and market needs.

Founded in 1992, Homart Group has 34 years of experience in the health and wellness industry. The company operates across multiple categories including nutritional supplements, skincare, functional dairy products and pet nutritional supplements, with a growing portfolio of Australian brands.

Participation in APP 2026 further strengthened Homart’s engagement with the professional pharmacy channel while expanding awareness of its brand portfolio within the industry.

Looking ahead, Homart Group will continue to develop innovative health products and expand its partnerships with pharmacies and healthcare professionals, bringing Australian health solutions to consumers both locally and globally.

The post Homart Showcases Five Brands at APP 2026, Strengthening Presence in the Pharmacy Channel appeared first on Homart Pharmaceuticals.

Guided by its philosophy of “minimalist, clean and verifiable,” Salt Lab specialises in magnesium-based wellness products. Addressing everyday lifestyle concerns such as sleep disturbance and muscle discomfort, the brand has developed a product portfolio spanning whole-body care and daily wellbeing. Known for its naturally derived formulations, Salt Lab is a leading online magnesium wellness brand in Australia and New Zealand, with a strong presence on Amazon and retail distribution through Nordstrom. The brand also maintains a commitment to sustainability.

This acquisition represents another significant milestone in Homart Group’s brand expansion, following its acquisitions of the 75-year-old Thompson’s and the 50-year-old Thursday Plantation in 2024. Leveraging Homart’s strengths in research and development, supply chain and global distribution channels, Salt Lab will accelerate its international expansion. Its strong online sales capability, expertise in the magnesium segment and engagement with younger consumers will further support Homart’s precision mind-and-body wellness strategy and long-term growth.

Homart Group is scheduled to list on the Australian Securities Exchange (ASX) in May this year. The addition of Salt Lab will enhance the Group’s overall product portfolio, strengthen e-commerce capability and engagement with younger consumers, and support long-term growth.

Homart Group CEO Lynn Yeh said:

“Salt Lab’s brand philosophy is closely aligned with Homart’s mission. By leveraging the Group’s capabilities, we will advance product development and expand global market reach. We believe the upcoming listing will bring further opportunities to all our brands.”

Homart Group CEO Lynn Yeh (right) and Salt Lab Founder Clementine (left)

Founded in 1992, Homart Group has operated in the health and wellness industry for 34 years. The Group owns 17 well-known brands including SpringLeaf, Thompson’s, Thursday Plantation, Petmima, Salt Lab and Autili. Its portfolio spans four major categories — nutritional supplements, skincare, functional dairy products and pet nutrition supplements — with products distributed across multiple international markets. The company is supported by robust quality standards, strong brand recognition and established distribution channels, and is highly regarded by industry partners and consumers.

Following its listing, Homart Group remains committed to bringing high-quality Australasian health products to families worldwide and supporting healthier lifestyles globally.

The post Homart Group Acquires Magnesium Wellness Brand Salt Lab, Further Expanding Its Health Portfolio appeared first on Homart Pharmaceuticals.

Guided by the Hainan Health Commission and the Chinese Pharmaceutical Association, and organized by the Lecheng Administration and the Hainan Institute of Health Industry, the exhibition brought together leading global institutions in innovative drugs, medical devices, medical nutrition, health foods, and life sciences. It is recognized as the most significant international health industry event ahead of the upcoming island-wide customs closure of the Hainan Free Trade Port.

At the exhibition’s key session — the Global Special Medical & Health Foods Sharing Forum — Homart Group Founder & CEO Lynn Yeh delivered a keynote speech as the invited representative of Australian enterprises. She provided a comprehensive overview of the evolution of Australia’s health supplement industry, its scientific research strengths, regulatory framework, and global influence, while presenting Homart’s 34 years of innovation.

In her keynote, Lynn Yeh outlined the three major development stages of Australia’s health industry since the early 20th century — from basic nutritional supplementation, to the rise of herbal and functional nutrition, to Australia becoming a globally recognized provider of high-standard health products. She noted that 14 Nobel Prize laureates have emerged from Australia’s life science fields, creating long-term momentum for innovation. Industry forecasts indicate that Australia’s health and nutrition market is expected to exceed AUD 9.5 billion by 2025, continuing strong global growth.

During the exhibition, Homart showcased several new products, including Thompson’s Milk Thistle 48000 and Brightening Capsules; SpringLeaf High-Strength Fish Oil + Vitamin D and the 7-in-1 Eye Care Capsule; TopLife premium functional nutrition series; and PETMIMA, Australia’s pet nutrition expert (with eight official import approvals issued by China’s Ministry of Agriculture). SpringLeaf has also received five NMPA overseas “Blue Hat” approvals, demonstrating its strong compliance capability in the Chinese market.

Throughout the event, Lynn Yeh was interviewed by CCTV, Hainan TV and China News Service, where she discussed Australia’s global competitiveness in the health industry, the strategic role of Lecheng’s “pilot-first” policy framework, and the international significance of Hainan’s upcoming island-wide customs closure.

Homart is currently applying for 16 core products to enter the Hainan Free Trade Port via the Lecheng Pilot Zone under the Health Food (Pilot) Program, covering sleep support, joint & gout management, beauty & skin health, eye nutrition, anti-fatigue, cardiovascular health, antioxidants, and men’s health — providing Chinese consumers with high-quality, internationally aligned nutrition solutions.

Homart stated that Boao Lecheng serves as a vital gateway for international health products to enter China and a key bridge for Australia–China cooperation in the health industry. The Group will continue leveraging Australia’s strict regulatory standards and scientific expertise to collaborate with Lecheng institutions, accelerating the introduction of high-quality Australian health products to consumers in China and around the world.

The post Homart Invited to the Boao Lecheng “Never Ending” International Innovation Drug and Equipment Exhibition, Where CEO Lynn Yeh Delivered a Keynote Speech and Engaged with Major Media Outlets appeared first on Homart Pharmaceuticals.

On 12 November 2025, Cosmoprof Asia officially opened in Hong Kong. As a leading Australian company in the health and beauty industry, Homart Group participated with its multi-brand portfolio, engaging global industry partners to explore the latest trends in health and beauty.

On the opening day, the Homart booth attracted strong attention from distributors, retailers, importers, cross-border e-commerce platforms, and industry media from around the world. The active discussions and continuous business enquiries reflected the growing international interest in wellness-driven beauty and high-quality Australian products.

During the exhibition, Homart showcased its innovation across health supplements, natural skincare, medical-grade beauty, and functional pet nutrition, highlighting Australia’s unique strengths in “nature + science.” Our onsite team provided product experience sessions, professional consultations, and market insights, helping global partners gain a deeper understanding of the potential of Australian health and beauty solutions.

Since its establishment in 1992, Homart has adhered to the brand philosophy of Health · Nature · Innovation. With multiple self-owned manufacturing facilities certified by TGA, cGMP, ISO, FDA and other international standards, Homart continues to bring trusted Australian-made products to markets worldwide.

Through this year’s Cosmoprof Asia, Homart further strengthened its global footprint in the health and beauty industry and looks forward to exploring new collaboration opportunities with international partners to drive the future of wellness and beauty.

The post Homart Group Shines at Cosmoprof Asia 2025 appeared first on Homart Pharmaceuticals.

At the expo, Homart and JD Health formalized a long-term strategic partnership focusing on flagship store operations, new product incubation, consumer education, and anti-counterfeiting traceability. The collaboration aims to strengthen brand building and service upgrades for Australian health products in China.

From left to right: Mr. John Madew, Senior Trade and Investment Commissioner and Deputy Consul-General; Ms. Lynn Yeh, CEO, Homart Group; the Hon Don Farrell, Australian Minister for Trade and Tourism; Ms. Changyue Song, Head of Cross-Border Business, JD Health; and Dr. Paul Grimes, CEO, Austrade.

From left to right: Ms. Lynn Yeh, CEO, Homart Group; Mr. Martin Ferreyra, Representative, Austrade; and Mr. Haohang Song, Vice President and General Manager of Nutrition and Health, JD Health.

In the presence of the Hon Don Farrell and Dr. Paul Grimes, CEO of Austrade, the strategic cooperation agreement was signed by Lynn Yeh, CEO of Homart Group, and Changyue Song, Head of Cross-border Business, JD Health. Lynn Yeh, Haohang Song, Vice President and General Manager of Nutrition and Health at JD Health, and Martin Ferreyra from Austrade jointly participated in the ribbon-cutting ceremony.

As Homart deepens its presence in China, it is also accelerating its global expansion. During the CIIE, Homart signed a strategic MOU with AliExpress, Alibaba Group’s international e-commerce platform, to strengthen collaboration in cross-border e-commerce, global marketing, and digital retail. The partnership aims to bring high-quality Australian-made health products to global consumers more efficiently.

The ribbon-cutting ceremony was attended by Lynn Yeh, CEO, Homart Group; Alfy Zhang, Country Manager for Australia and New Zealand, AliExpress; Martin Ferreyra from Austrade; and Ben Lazzaro, CEO, Australian Made.

From left to right: Ms. Lynn Yeh, CEO, Homart Group; Mr. Ben Lazzaro, CEO, Australian Made; Mr. Martin Ferreyra, Representative, Austrade; and Ms. Alfy Zhang, Country Manager for Australia and New Zealand, AliExpress.

Under the MOU, AliExpress will assist Homart in establishing an official flagship store on its platform, co-launching marketing and promotional campaigns, and enhancing customer experience. Homart, in turn, will provide high-quality, Australian-made health products with a stable and reliable supply chain.

The initial rollout will feature brands such as SpringLeaf, TopLife, GrandPawPaw, and CHÉRI, covering about 40 SKUs, with plans to expand to 200 SKUs within three years and reach cumulative sales of AUD 30 million.

As a long-time participant in the CIIE, Homart has witnessed the deepening cooperation between China and Australia in the health industry. Through its new partnerships with China’s leading e-commerce platforms, the company is building an international strategy centered on the Chinese market while advancing toward global expansion.

“CIIE is not just a showcase — it’s a bridge for collaboration,” said Lynn Yeh, CEO of Homart Group. “Through these partnerships, we hope to bring more premium Australian health products to China and the world. Homart will continue to leverage CIIE as a key platform to strengthen cooperation with partners in China and globally, contributing to a more open, innovative, and sustainable global health ecosystem.”

The post Australian Health Supplement Leader Homart Group Expands Global Footprint Through CIIE Partnerships with JD Health and AliExpress appeared first on Homart Pharmaceuticals.